< Terug naar vorige pagina


Ways forward for tolerance-inducing cellular therapies

Tijdschriftbijdrage - e-publicatie

Ondertitel:an AFACTT perspective
Clinical studies with cellular therapies using tolerance-inducing cells, such as tolerogenic antigen-presenting cells (tolAPC) and regulatory T cells (Treg) for the prevention of transplant rejection and the treatment of autoimmune diseases have been expanding the last decade. In this perspective, we will summarize the current perspectives of the clinical application of both tolAPC and Treg, and will address future directions and the importance of immunomonitoring in clinical studies that will result in progress in the field.
Tijdschrift: Frontiers in Immunology
Volume: 10
Aantal pagina's: 20
Jaar van publicatie:2019